← Open Payments lookup

RICHARD YOUNG: Open Payments

NPI 1417371881 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,712 in 134 payments from 12 companies in 2025. Trend: 2023 $2,415 · 2024 $1,793 · 2025 $2,712

Food & beverage: $2,491Education: $221
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.33$688
Otsuka America Pharmaceutical, Inc.21$618
Janssen Pharmaceuticals, Inc11$343
E.R. Squibb & Sons, L.L.C.23$300
Neurocrine BioSciences, Inc.10$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$231
ABBVIE INC.10$141
Alkermes, Inc.3$54
Vanda Pharmaceuticals Inc.3$53
Corium, LLC1$17

Products named: UZEDY, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII, INGREZZA, CAPLYTA, INVEGA SUSTENNA, INVEGA.

Industry payments across TX — which companies pay providers there.